Genevant Sciences

Biotechnology ResearchBritish Columbia, Canada11-50 Employees

Genevant is a technology-focused nucleic acid delivery company with world-class platforms, the industry’s most robust and expansive lipid nanoparticle (LNP) patent estate and decades of expertise in nucleic acid drug development.  We leverage our world-class delivery systems and related technologies to bring new medicines to patients who need them. We do this by selectively collaborating with leading pharma and biotech companies and fostering a culture of innovation that allows us to maintain our leadership position in the space. 

•	Best-in-class LNP + next generation ligand conjugate technologies
•	First and only FDA-approved siRNA-LNP utilizes Genevant technology
•	Nucleic acid payload design expertise
•	Several hundred patents worldwide
•	LNP technology evaluated in more than a dozen clinical programs, 
        representing hundreds of subjects and patients
•	An established leader in delivery to the liver, now focusing capabilities 
        on other tissues and cell types
•	Experienced team with deep technical expertise and a track record of 
        innovation and creative corporate partnering

Sign up for free to view info

Email Format Employee directory